Cargando…

Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy

Chronic kidney disease guidelines and disease modifying therapy have seen a dramatic shift in the last 5 years. The SGLT2 inhibitor class of medications has been catapulted from hyperglycemia management medications, to cardiovascular and kidney disease improvement therapies. Multiple trials looking...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colbert, Gates B, Madariaga, Hector M, Gaddy, Anna, Elrggal, Mohamed E, Lerma, Edgar V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901477/ https://www.ncbi.nlm.nih.gov/pubmed/36756278 http://dx.doi.org/10.2147/TCRM.S398163

Ejemplares similares

Management of Hypertension in Diabetic Kidney Disease
por: Colbert, Gates B., et al.
Publicado: (2023)

Clinical Efficacy, Safety, Tolerability, and Real-World Data of Patiromer for the Treatment of Hyperkalemia
por: Colbert, Gates, et al.
Publicado: (2022)

Empagliflozin in Patients with Chronic Kidney Disease
por: Herrington, William G., et al.
Publicado: (2023)

Dapagliflozin versus empagliflozin in patients with chronic kidney disease
por: Alnsasra, Hilmi, et al.
Publicado: (2023)

Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
por: Waziri, Bala, et al.
Publicado: (2019)

Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology
por: Venuthurupalli, Sree K., et al.
Publicado: (2018)

Prevention of Chronic kidney disease (CKD) in children
por: Pecoraro, Carmine
Publicado: (2015)

Chronic kidney disease (CKD) in disadvantaged populations
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2015)

CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia
por: Venuthurupalli, Sree K., et al.
Publicado: (2017)

Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease
por: Hojná, Silvie, et al.
Publicado: (2022)

Impact of empagliflozin on diabetic kidney disease
por: Koya, Daisuke
Publicado: (2017)

Nutritional Status in Adults with Predialysis Chronic Kidney Disease: KNOW-CKD Study
por: Hyun, Young Youl, et al.
Publicado: (2017)

Vitamin D resistance in chronic kidney disease (CKD)
por: Parikh, Amay, et al.
Publicado: (2014)

Vitamin D and methylarginines in chronic kidney disease (CKD)
por: Torino, Claudia, et al.
Publicado: (2017)

The Role of Wnt Signalling in Chronic Kidney Disease (CKD)
por: Malik, Soniya A., et al.
Publicado: (2020)

Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective
por: Lohia, Sonnal, et al.
Publicado: (2022)

Atherosclerosis Specific Features in Chronic Kidney Disease (CKD)
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Periodontal disease as a predictor of chronic kidney disease (CKD) stage in older adults
por: Valenzuela-Narváez, Rocío Violeta, et al.
Publicado: (2021)

Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD
por: Norris, Keith C., et al.
Publicado: (2019)

Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
por: Hamano, Takayuki, et al.
Publicado: (2022)

Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD
por: Yamada, Shunsuke, et al.
Publicado: (2023)

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors and CKD: Are You a #Flozinator?
por: Krishnan, Anoushka, et al.
Publicado: (2023)

Role of empagliflozin in chronic lithium toxicity
por: Dyson, Vicki
Publicado: (2022)

Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages
por: Lin, Yi-Hsuan, et al.
Publicado: (2019)

Anemia and Iron Deficiency in Children with Chronic Kidney Disease (CKD): Data from the Know-Ped CKD Study
por: Lee, Keum Hwa, et al.
Publicado: (2019)

Correction to: Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
Publicado: (2022)

Combination of Empagliflozin and Metformin Therapy: A Consideration of its Place in Type 2 Diabetes Therapy
por: Goldman, Jennifer D
Publicado: (2018)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy
por: Juluri, Krishna R, et al.
Publicado: (2022)

Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients
por: Lee, Hee Jeong, et al.
Publicado: (2018)

Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solved
por: Villalvazo, Priscila, et al.
Publicado: (2021)

Development and Preliminary Psychometric Testing of an Adult Chronic Kidney Disease Self-Management (CKD-SM) Questionnaire
por: Smekal, Michelle D., et al.
Publicado: (2021)

Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
por: Ravani, Pietro, et al.
Publicado: (2013)

CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia
por: Venuthurupalli, Sree K., et al.
Publicado: (2012)

Optimizing Enteral Nutrition for Growth in Pediatric Chronic Kidney Disease (CKD)
por: Nelms, Christina L.
Publicado: (2018)

Practical Strategy for Treating Chronic Kidney Disease (CKD)-Associated with Hypertension
por: Nagata, Daisuke, et al.
Publicado: (2020)

Mediterranean Diet and Chronic Kidney Disease (CKD): A Practical Approach
por: Pérez-Torres, Almudena, et al.
Publicado: (2022)

Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD
por: Park, Haesuk, et al.
Publicado: (2017)

Empagliflozin in the treatment of type 2 diabetes: evidence to date
por: Shubrook, Jay H, et al.
Publicado: (2015)

SerpinA3 in the Early Recognition of Acute Kidney Injury to Chronic Kidney Disease (CKD) transition in the rat and its Potentiality in the Recognition of Patients with CKD
por: Sánchez-Navarro, Andrea, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vn63svrk39rjskroh51a338cgo